Pulmonary hypertension in patients with interstitial lung disease: a tool for early detection

Abstract Pulmonary hypertension (PH) complicates the treatment of interstitial lung disease (ILD) patients resulting in poor functional status and worse outcomes. Early recognition of PH in ILD is important for initiating therapy and considering lung transplantation. However, no standard exists rega...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí: Raj Parikh, Ippokratis Konstantinidis, David M. O'Sullivan, Harrison W. Farber
Formáid: Alt
Teanga:English
Foilsithe / Cruthaithe: Wiley 2022-10-01
Sraith:Pulmonary Circulation
Ábhair:
Rochtain ar líne:https://doi.org/10.1002/pul2.12141
_version_ 1828085428109967360
author Raj Parikh
Ippokratis Konstantinidis
David M. O'Sullivan
Harrison W. Farber
author_facet Raj Parikh
Ippokratis Konstantinidis
David M. O'Sullivan
Harrison W. Farber
author_sort Raj Parikh
collection DOAJ
description Abstract Pulmonary hypertension (PH) complicates the treatment of interstitial lung disease (ILD) patients resulting in poor functional status and worse outcomes. Early recognition of PH in ILD is important for initiating therapy and considering lung transplantation. However, no standard exists regarding which patients to screen for PH‐ILD or the optimal method to do so. The aim of this study was to create a risk assessment tool that could reliably predict PH in ILD patients. We developed a PH‐ILD Detection tool that incorporated history, exam, 6‐min walk distance, diffusion capacity for carbon monoxide, chest imaging, and cardiac biomarkers to create an eight‐component score. This tool was analyzed retrospectively in 154 ILD patients where each patient was given a score ranging from 0 to 12. The sensitivity (SN) and specificity (SP) of the PH‐ILD Detection tool and an area‐under‐the‐curve (AUC) were calculated. In this cohort, 74 patients (48.1%) had PH‐ILD. A score of ≥6 on the PH‐ILD Detection tool was associated with a diagnosis of PH‐ILD (SN: 86.5%; SP: 86.3%; area‐under‐the‐curve: 0.920, p < 0.001). The PH‐ILD Detection tool provides high SN and SP for detecting PH in ILD patients. With confirmation in larger cohorts, this tool could improve the diagnosis of PH in ILD and may suggest further testing with right heart catheterization and earlier intervention with inhaled treprostinil and/or lung transplant evaluation.
first_indexed 2024-04-11T04:39:52Z
format Article
id doaj.art-1c10c38b51ba460eb8b7fa85a58f44c0
institution Directory Open Access Journal
issn 2045-8940
language English
last_indexed 2024-04-11T04:39:52Z
publishDate 2022-10-01
publisher Wiley
record_format Article
series Pulmonary Circulation
spelling doaj.art-1c10c38b51ba460eb8b7fa85a58f44c02022-12-28T07:32:42ZengWileyPulmonary Circulation2045-89402022-10-01124n/an/a10.1002/pul2.12141Pulmonary hypertension in patients with interstitial lung disease: a tool for early detectionRaj Parikh0Ippokratis Konstantinidis1David M. O'Sullivan2Harrison W. Farber3Division of Pulmonary, Critical Care, and Sleep Hartford Hospital Hartford Connecticut USADepartment of Internal Medicine University of Connecticut Farmington Connecticut USADepartment of Research Administration Hartford HealthCare Hartford Connecticut USADivision of Pulmonary, Sleep and Critical Care Medicine Tufts Medical Center Boston Massachusetts USAAbstract Pulmonary hypertension (PH) complicates the treatment of interstitial lung disease (ILD) patients resulting in poor functional status and worse outcomes. Early recognition of PH in ILD is important for initiating therapy and considering lung transplantation. However, no standard exists regarding which patients to screen for PH‐ILD or the optimal method to do so. The aim of this study was to create a risk assessment tool that could reliably predict PH in ILD patients. We developed a PH‐ILD Detection tool that incorporated history, exam, 6‐min walk distance, diffusion capacity for carbon monoxide, chest imaging, and cardiac biomarkers to create an eight‐component score. This tool was analyzed retrospectively in 154 ILD patients where each patient was given a score ranging from 0 to 12. The sensitivity (SN) and specificity (SP) of the PH‐ILD Detection tool and an area‐under‐the‐curve (AUC) were calculated. In this cohort, 74 patients (48.1%) had PH‐ILD. A score of ≥6 on the PH‐ILD Detection tool was associated with a diagnosis of PH‐ILD (SN: 86.5%; SP: 86.3%; area‐under‐the‐curve: 0.920, p < 0.001). The PH‐ILD Detection tool provides high SN and SP for detecting PH in ILD patients. With confirmation in larger cohorts, this tool could improve the diagnosis of PH in ILD and may suggest further testing with right heart catheterization and earlier intervention with inhaled treprostinil and/or lung transplant evaluation.https://doi.org/10.1002/pul2.12141idiopathic pulmonary fibrosisinterstitial lung diseaseprostacyclinpulmonary hypertensiontreprostinil
spellingShingle Raj Parikh
Ippokratis Konstantinidis
David M. O'Sullivan
Harrison W. Farber
Pulmonary hypertension in patients with interstitial lung disease: a tool for early detection
Pulmonary Circulation
idiopathic pulmonary fibrosis
interstitial lung disease
prostacyclin
pulmonary hypertension
treprostinil
title Pulmonary hypertension in patients with interstitial lung disease: a tool for early detection
title_full Pulmonary hypertension in patients with interstitial lung disease: a tool for early detection
title_fullStr Pulmonary hypertension in patients with interstitial lung disease: a tool for early detection
title_full_unstemmed Pulmonary hypertension in patients with interstitial lung disease: a tool for early detection
title_short Pulmonary hypertension in patients with interstitial lung disease: a tool for early detection
title_sort pulmonary hypertension in patients with interstitial lung disease a tool for early detection
topic idiopathic pulmonary fibrosis
interstitial lung disease
prostacyclin
pulmonary hypertension
treprostinil
url https://doi.org/10.1002/pul2.12141
work_keys_str_mv AT rajparikh pulmonaryhypertensioninpatientswithinterstitiallungdiseaseatoolforearlydetection
AT ippokratiskonstantinidis pulmonaryhypertensioninpatientswithinterstitiallungdiseaseatoolforearlydetection
AT davidmosullivan pulmonaryhypertensioninpatientswithinterstitiallungdiseaseatoolforearlydetection
AT harrisonwfarber pulmonaryhypertensioninpatientswithinterstitiallungdiseaseatoolforearlydetection